SF01_HUMAN - dbPTM
SF01_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SF01_HUMAN
UniProt AC Q15637
Protein Name Splicing factor 1
Gene Name SF1
Organism Homo sapiens (Human).
Sequence Length 639
Subcellular Localization Nucleus.
Protein Description Necessary for the ATP-dependent first step of spliceosome assembly. Binds to the intron branch point sequence (BPS) 5'-UACUAAC-3' of the pre-mRNA. May act as transcription repressor..
Protein Sequence MATGANATPLDFPSKKRKRSRWNQDTMEQKTVIPGMPTVIPPGLTREQERAYIVQLQIEDLTRKLRTGDLGIPPNPEDRSPSPEPIYNSEGKRLNTREFRTRKKLEEERHNLITEMVALNPDFKPPADYKPPATRVSDKVMIPQDEYPEINFVGLLIGPRGNTLKNIEKECNAKIMIRGKGSVKEGKVGRKDGQMLPGEDEPLHALVTANTMENVKKAVEQIRNILKQGIETPEDQNDLRKMQLRELARLNGTLREDDNRILRPWQSSETRSITNTTVCTKCGGAGHIASDCKFQRPGDPQSAQDKARMDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPRPAAPANNPPPPSLMSTTQSRPPWMNSGPSESRPYHGMHGGGPGGPGGGPHSFPHPLPSLTGGHGGHPMQHNPNGPPPPWMQPPPPPMNQGPHPPGHHGPPPMDQYLGSTPVGSGVYRLHQGKGMMPPPPMGMMPPPPPPPSGQPPPPPSGPLPPWQQQQQQPPPPPPPSSSMASSTPLPWQQNTTTTTTSAGTGSIPPWQQQQAAAAASPGAPQMQGNPTMVPLPPGVQPPLPPGAPPPPPPPPPGSAGMMYAPPPPPPPPMDPSNFVTMMGMGVAGMPPFGMPPAPPPPPPQN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MATGANATP
------CCCCCCCCC
18.1022223895
3Phosphorylation-----MATGANATPL
-----CCCCCCCCCC
35.2127251275
8PhosphorylationMATGANATPLDFPSK
CCCCCCCCCCCCCCH
24.9629255136
8 (in isoform 5)Phosphorylation-24.9622199227
14PhosphorylationATPLDFPSKKRKRSR
CCCCCCCCHHHCCCC
51.2929255136
15UbiquitinationTPLDFPSKKRKRSRW
CCCCCCCHHHCCCCC
57.76-
15AcetylationTPLDFPSKKRKRSRW
CCCCCCCHHHCCCCC
57.7625953088
16UbiquitinationPLDFPSKKRKRSRWN
CCCCCCHHHCCCCCC
68.44-
20PhosphorylationPSKKRKRSRWNQDTM
CCHHHCCCCCCCCHH
44.6917287340
26PhosphorylationRSRWNQDTMEQKTVI
CCCCCCCHHHCCCCC
16.9128450419
31PhosphorylationQDTMEQKTVIPGMPT
CCHHHCCCCCCCCCC
24.3021406692
36SulfoxidationQKTVIPGMPTVIPPG
CCCCCCCCCCCCCCC
1.7928183972
38PhosphorylationTVIPGMPTVIPPGLT
CCCCCCCCCCCCCCC
23.3621406692
45PhosphorylationTVIPPGLTREQERAY
CCCCCCCCHHHHHEE
37.7721406692
62PhosphorylationQLQIEDLTRKLRTGD
EEEHHHHHHHHHCCC
37.7726074081
67PhosphorylationDLTRKLRTGDLGIPP
HHHHHHHCCCCCCCC
45.5522167270
80PhosphorylationPPNPEDRSPSPEPIY
CCCCCCCCCCCCCCC
41.8919664994
80 (in isoform 2)Phosphorylation-41.8918669648
82PhosphorylationNPEDRSPSPEPIYNS
CCCCCCCCCCCCCCC
43.0419664994
82 (in isoform 2)Phosphorylation-43.0418669648
87PhosphorylationSPSPEPIYNSEGKRL
CCCCCCCCCCCCCCC
24.2922167270
87 (in isoform 2)Phosphorylation-24.2918669648
89PhosphorylationSPEPIYNSEGKRLNT
CCCCCCCCCCCCCCH
30.6522167270
89 (in isoform 2)Phosphorylation-30.6518669648
92AcetylationPIYNSEGKRLNTREF
CCCCCCCCCCCHHHH
50.0525953088
96O-linked_GlycosylationSEGKRLNTREFRTRK
CCCCCCCHHHHHHHH
35.8530059200
112 (in isoform 5)Phosphorylation-4.1330266825
130AcetylationFKPPADYKPPATRVS
CCCCCCCCCCCCCCC
45.1025953088
134PhosphorylationADYKPPATRVSDKVM
CCCCCCCCCCCCCEE
37.0628348404
137PhosphorylationKPPATRVSDKVMIPQ
CCCCCCCCCCEECCC
28.5528348404
145 (in isoform 5)Phosphorylation-52.6327251275
151 (in isoform 5)Phosphorylation-24.7227251275
165AcetylationGPRGNTLKNIEKECN
CCCCCHHHHHHHHHC
54.5727452117
169AcetylationNTLKNIEKECNAKIM
CHHHHHHHHHCCEEE
64.8625953088
174UbiquitinationIEKECNAKIMIRGKG
HHHHHCCEEEECCCC
20.86-
174AcetylationIEKECNAKIMIRGKG
HHHHHCCEEEECCCC
20.8625953088
205 (in isoform 5)Phosphorylation-16.0627251275
207 (in isoform 5)Phosphorylation-5.0127251275
208PhosphorylationEPLHALVTANTMENV
CCHHHHHCHHHHHHH
18.2925332170
217AcetylationNTMENVKKAVEQIRN
HHHHHHHHHHHHHHH
54.0720167786
217UbiquitinationNTMENVKKAVEQIRN
HHHHHHHHHHHHHHH
54.07-
227UbiquitinationEQIRNILKQGIETPE
HHHHHHHHCCCCCCC
42.5622053931
227 (in isoform 2)Ubiquitination-42.5621890473
227 (in isoform 6)Ubiquitination-42.5621890473
227UbiquitinationEQIRNILKQGIETPE
HHHHHHHHCCCCCCC
42.5621890473
227AcetylationEQIRNILKQGIETPE
HHHHHHHHCCCCCCC
42.5625953088
227 (in isoform 1)Ubiquitination-42.5621890473
227 (in isoform 3)Ubiquitination-42.5621890473
227 (in isoform 4)Ubiquitination-42.5621890473
232PhosphorylationILKQGIETPEDQNDL
HHHCCCCCCCCHHHH
30.0229255136
253PhosphorylationELARLNGTLREDDNR
HHHHHHCCCCCCCCC
22.9025159151
263MethylationEDDNRILRPWQSSET
CCCCCCCCCCCCCCC
28.21115916541
267PhosphorylationRILRPWQSSETRSIT
CCCCCCCCCCCCCCC
26.6928450419
268PhosphorylationILRPWQSSETRSITN
CCCCCCCCCCCCCCC
28.0828450419
270PhosphorylationRPWQSSETRSITNTT
CCCCCCCCCCCCCCE
31.5027251275
272PhosphorylationWQSSETRSITNTTVC
CCCCCCCCCCCCEEE
40.9828450419
274PhosphorylationSSETRSITNTTVCTK
CCCCCCCCCCEEECC
27.9728450419
276PhosphorylationETRSITNTTVCTKCG
CCCCCCCCEEECCCC
16.3828450419
277PhosphorylationTRSITNTTVCTKCGG
CCCCCCCEEECCCCC
18.6928450419
280PhosphorylationITNTTVCTKCGGAGH
CCCCEEECCCCCCCC
25.6528450419
281AcetylationTNTTVCTKCGGAGHI
CCCEEECCCCCCCCC
26.2525953088
282S-palmitoylationNTTVCTKCGGAGHIA
CCEEECCCCCCCCCC
3.0721044946
292S-palmitoylationAGHIASDCKFQRPGD
CCCCCCCCCCCCCCC
4.3921044946
293AcetylationGHIASDCKFQRPGDP
CCCCCCCCCCCCCCC
49.9025953088
302PhosphorylationQRPGDPQSAQDKARM
CCCCCCCHHHHHHHC
33.0325022875
306AcetylationDPQSAQDKARMDKEY
CCCHHHHHHHCCHHH
26.3023749302
306UbiquitinationDPQSAQDKARMDKEY
CCCHHHHHHHCCHHH
26.30-
3062-HydroxyisobutyrylationDPQSAQDKARMDKEY
CCCHHHHHHHCCHHH
26.30-
313PhosphorylationKARMDKEYLSLMAEL
HHHCCHHHHHHHHHH
13.82-
315O-linked_GlycosylationRMDKEYLSLMAELGE
HCCHHHHHHHHHHCC
18.3930059200
328O-linked_GlycosylationGEAPVPASVGSTSGP
CCCCCCCCCCCCCCC
22.4230059200
331O-linked_GlycosylationPVPASVGSTSGPATT
CCCCCCCCCCCCCCC
19.7630059200
332O-linked_GlycosylationVPASVGSTSGPATTP
CCCCCCCCCCCCCCC
31.6030059200
333O-linked_GlycosylationPASVGSTSGPATTPL
CCCCCCCCCCCCCCC
44.4730059200
337O-linked_GlycosylationGSTSGPATTPLASAP
CCCCCCCCCCCCCCC
31.8930059200
337PhosphorylationGSTSGPATTPLASAP
CCCCCCCCCCCCCCC
31.8928348404
338PhosphorylationSTSGPATTPLASAPR
CCCCCCCCCCCCCCC
20.5728348404
338O-linked_GlycosylationSTSGPATTPLASAPR
CCCCCCCCCCCCCCC
20.5730059200
342O-linked_GlycosylationPATTPLASAPRPAAP
CCCCCCCCCCCCCCC
46.6330059200
345DimethylationTPLASAPRPAAPANN
CCCCCCCCCCCCCCC
32.95-
345MethylationTPLASAPRPAAPANN
CCCCCCCCCCCCCCC
32.9555533399
352 (in isoform 5)Ubiquitination-53.1921890473
357 (in isoform 5)Phosphorylation-42.3427251275
365DimethylationLMSTTQSRPPWMNSG
HHCCCCCCCCCCCCC
31.33-
365MethylationLMSTTQSRPPWMNSG
HHCCCCCCCCCCCCC
31.3352718103
392 (in isoform 5)Phosphorylation-49.9827251275
397 (in isoform 5)Phosphorylation-6.1527251275
427 (in isoform 5)Phosphorylation-27.5327251275
454 (in isoform 6)Ubiquitination-21.8621890473
455 (in isoform 6)Phosphorylation-30.12-
463 (in isoform 5)Phosphorylation-1.6127251275
463 (in isoform 6)Phosphorylation-1.6125159151
466 (in isoform 6)Phosphorylation-20.1028152594
467 (in isoform 6)Methylation-36.7424129315
521O-linked_GlycosylationSSSMASSTPLPWQQN
CCCCCCCCCCCCCCC
26.7530059200
522 (in isoform 6)Phosphorylation-38.07-
529 (in isoform 4)Phosphorylation-22.6026434776
539 (in isoform 6)Phosphorylation-23.7426714015
606 (in isoform 2)Phosphorylation-45.6526714015
615 (in isoform 3)Phosphorylation-1.5122798277
654 (in isoform 5)Phosphorylation-26434776
662 (in isoform 5)Methylation--
670 (in isoform 5)Methylation--

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
20SPhosphorylationKinasePRKG1Q13976
GPS
20SPhosphorylationKinasePKG-Uniprot
80SPhosphorylationKinaseUHMK1Q8TAS1
GPS
82SPhosphorylationKinaseUHMK1Q8TAS1
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
20SPhosphorylation

10449420
463SPhosphorylation

16964243

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SF01_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DDX17_HUMANDDX17physical
16189514
WWP2_HUMANWWP2physical
16189514
RBPMS_HUMANRBPMSphysical
16189514
U2AF2_HUMANU2AF2physical
16189514
EWS_HUMANEWSR1physical
9660765
U2AF2_HUMANU2AF2physical
9512519
TCRG1_HUMANTCERG1physical
11604498
U2AF2_HUMANU2AF2physical
9150140
ZN461_HUMANZNF461physical
16595694
PML_HUMANPMLphysical
21360626
NFKB1_HUMANNFKB1physical
12917325
HDAC5_HUMANHDAC5physical
12917325
U5S1_HUMANEFTUD2physical
22939629
VDAC1_HUMANVDAC1physical
22939629
MPLKI_HUMANMPLKIPphysical
22939629
ZC11A_HUMANZC3H11Aphysical
22939629
TMED4_HUMANTMED4physical
22939629
TOM40_HUMANTOMM40physical
22939629
SRPRB_HUMANSRPRBphysical
22939629
VDAC3_HUMANVDAC3physical
22939629
STIM1_HUMANSTIM1physical
22939629
UB2L3_HUMANUBE2L3physical
22939629
VAMP2_HUMANVAMP2physical
22939629
TAGL_HUMANTAGLNphysical
22939629
ZFR_HUMANZFRphysical
22939629
SORC3_HUMANSORCS3physical
22939629
SIN3A_HUMANSIN3Aphysical
22939629
STOM_HUMANSTOMphysical
22939629
SRP09_HUMANSRP9physical
22939629
SF3A1_HUMANSF3A1physical
22365833
SF3B4_HUMANSF3B4physical
22365833
SPF45_HUMANRBM17physical
22365833
U2AF2_HUMANU2AF2physical
22365833
RBM10_HUMANRBM10physical
22365833
SF01_HUMANSF1physical
22365833
ILF3_HUMANILF3physical
22365833
U5S1_HUMANEFTUD2physical
22365833
SPF27_HUMANBCAS2physical
22365833
WDR83_HUMANWDR83physical
22365833
RBM7_HUMANRBM7physical
22365833
DDX17_HUMANDDX17physical
22365833
HNRPK_HUMANHNRNPKphysical
22365833
HNRL1_HUMANHNRNPUL1physical
22365833
RBM4_HUMANRBM4physical
22365833
MEP50_HUMANWDR77physical
22365833
HNRPF_HUMANHNRNPFphysical
22365833
HNRH1_HUMANHNRNPH1physical
22365833
HNRH2_HUMANHNRNPH2physical
22365833
IL7RA_HUMANIL7Rphysical
23151878
RANB3_HUMANRANBP3physical
22863883
MKRN3_HUMANMKRN3physical
25416956
CIAO1_HUMANCIAO1physical
25416956
F168A_HUMANFAM168Aphysical
25416956
TRI69_HUMANTRIM69physical
25416956
KR261_HUMANKRTAP26-1physical
25416956
CAB39_HUMANCAB39physical
26344197
CCD25_HUMANCCDC25physical
26344197
UBE2N_HUMANUBE2Nphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SF01_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-80; SER-82; TYR-87 AND SER-89, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-80; SER-82; TYR-87 AND SER-89, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80; SER-82 AND SER-89,PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463 (ISOFORM 6), ANDMASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-80; SER-82 ANDTYR-87, AND MASS SPECTROMETRY.
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline.";
Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
Electrophoresis 28:2027-2034(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-82, AND MASSSPECTROMETRY.
"Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependentprotein kinase regulates spliceosome assembly.";
Wang X., Bruderer S., Rafi Z., Xue J., Milburn P.J., Kraemer A.,Robinson P.J.;
EMBO J. 18:4549-4559(1999).
Cited for: PROTEIN SEQUENCE OF 19-28; 94-103; 228-239 AND 298-308, FUNCTION,INTERACTION WITH U2AF2, MUTAGENESIS OF SER-20, AND PHOSPHORYLATION ATSER-20.

TOP